SEC Filing Summary: Marathon Patent Group, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Marathon Patent Group, Inc. on March 11, 2013, covering events that occurred on March 8, 2013. The filing primarily addresses significant changes to the Company's Board of Directors, including the resignation of two directors and the appointment of two new independent directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance changes rather than financial performance data.
Material Changes
- Resignations: Mr. Joshua Bleak and Mr. David Rector resigned from the Board of Directors on March 8, 2013, for personal reasons. The Company stated there was no disagreement with management regarding operations, policies, or practices.
- Appointments: The Board appointed Mr. Craig Nard and Mr. William Rosellini to fill the vacancies. Both were determined to qualify as independent directors under NASDAQ rules.
- Compensation Agreements:
- Craig Nard: Granted 5-year stock options for 100,000 shares. Vesting schedule: 33% at year 1, 33% at year 2, and 34% at year 3. Strike price based on the March 8, 2013 closing price on the OTC Bulletin Board.
- William Rosellini: Granted 5-year stock options for 100,000 shares with identical vesting terms and strike price basis as Mr. Nard.
Outlook, Risks, and Management Commentary
Management highlighted the specific expertise the new directors bring to the Company:
- Craig Nard: A Professor of Law and expert in patent litigation and intellectual property, expected to provide value through his academic and legal experience.
- William Rosellini: Founder and Chairman of Microtransponder Inc., bringing medical technology expertise and experience in raising venture funding and NIH grants.
The filing notes that a press release was issued on March 11, 2013, regarding these events. No specific financial risks or contingencies were detailed in this document.
Investor Verification Checklist
- Verify the strike price of the 200,000 total options granted to the new directors based on the March 8, 2013 OTC Bulletin Board closing price.
- Review the full text of the Independent Director Agreements (Exhibits 10.1 and 10.2) for specific clawback and termination provisions.
- Confirm the Company's current stock plan limits to ensure the new grants are within authorized share counts.
- Check the March 11, 2013 press release (Exhibit 99.1) for additional context on the Board's strategic direction.